TG Therapeutics To Present Real-World, Pediatric Study Design And Biomarker Data For BRIUMVI In Multiple Sclerosis At ACTRIMS Annual Forum

TG Therapeutics, Inc. -2.58%

TG Therapeutics, Inc.

TGTX

28.52

-2.58%

TG Therapeutics To Present Real-World, Pediatric Study Design And Biomarker Data For BRIUMVI In Multiple Sclerosis At ACTRIMS Annual Forum
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via